Literature DB >> 11884380

Targeting CCR2 or CD18 inhibits experimental in-stent restenosis in primates: inhibitory potential depends on type of injury and leukocytes targeted.

Christopher Horvath1, Frederick G P Welt, Mark Nedelman, Patricia Rao, Campbell Rogers.   

Abstract

A central role for leukocytes in neointimal hyperplasia after arterial injury is suspected. However, the relative importance of neutrophils and monocytes in balloon or stent-induced injury are not well understood, and mechanistic targeting of leukocyte recruitment or function is crude. We determined the temporal and spatial distribution of different leukocytes after balloon and stent-induced injury in primate iliac arteries. Based on these data, we targeted neutrophil and monocyte recruitment selectively after angioplasty or stent implantation and demonstrated that monocyte-specific blockade achieved via blockade of the MCP-1 receptor CCR2, was effective at reducing neointimal hyperplasia after stenting. In contrast, combined neutrophil and monocyte blockade achieved by targeting the leukocyte beta(2)-integrin beta-subunit CD18 was required to reduce neointimal hyperplasia after balloon injury. Distinct patterns of leukocyte infiltration in balloon versus stent-injured arteries predict distinct mechanisms for antiinflammatory strategies targeting neutrophils or monocytes in primates and may assist design of effective clinical strategies for optimizing vascular interventions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11884380     DOI: 10.1161/hh0402.105956

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  19 in total

1.  Neutrophils alter the inflammatory milieu by signal-dependent translation of constitutive messenger RNAs.

Authors:  Stephan W Lindemann; Christian C Yost; Melvin M Denis; Thomas M McIntyre; Andrew S Weyrich; Guy A Zimmerman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-26       Impact factor: 11.205

2.  The transcription factor ETS-1 mediates proinflammatory responses and neointima formation in carotid artery endoluminal vascular injury.

Authors:  Wenguang Feng; Dongqi Xing; Ping Hua; Yun Zhang; Yiu-Fai Chen; Suzanne Oparil; Edgar A Jaimes
Journal:  Hypertension       Date:  2010-04-05       Impact factor: 10.190

Review 3.  Lipaemia, inflammation and atherosclerosis: novel opportunities in the understanding and treatment of atherosclerosis.

Authors:  Antonie J H H M van Oostrom; Jeroen van Wijk; Manuel Castro Cabezas
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 4.  Adipose tissue inflammation in the pathogenesis of type 2 diabetes.

Authors:  Ayano Kohlgruber; Lydia Lynch
Journal:  Curr Diab Rep       Date:  2015-11       Impact factor: 4.810

Review 5.  Inflammation as a mechanism and therapeutic target for in-stent restenosis.

Authors:  Douglas E Drachman; Daniel I Simon
Journal:  Curr Atheroscler Rep       Date:  2005-02       Impact factor: 5.113

6.  An engineered monomer of CCL2 has anti-inflammatory properties emphasizing the importance of oligomerization for chemokine activity in vivo.

Authors:  Tracy M Handel; Zoë Johnson; David H Rodrigues; Adriana C Dos Santos; Rocco Cirillo; Valeria Muzio; Simona Riva; Matthias Mack; Maud Déruaz; Frédéric Borlat; Pierre-Alain Vitte; Timothy N C Wells; Mauro M Teixeira; Amanda E I Proudfoot
Journal:  J Leukoc Biol       Date:  2008-07-28       Impact factor: 4.962

7.  Monocyte chemoattractant protein-1/CCR2 axis promotes vein graft neointimal hyperplasia through its signaling in graft-extrinsic cell populations.

Authors:  Chunhua Fu; Peng Yu; Ming Tao; Tushar Gupta; Lyle L Moldawer; Scott A Berceli; Zhihua Jiang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-08-16       Impact factor: 8.311

8.  Cyclooxygenase-2-derived prostaglandin E₂ promotes injury-induced vascular neointimal hyperplasia through the E-prostanoid 3 receptor.

Authors:  Jian Zhang; Fangfang Zou; Juan Tang; Qianqian Zhang; Yanjun Gong; Qingsong Wang; Yujun Shen; Lixia Xiong; Richard M Breyer; Michael Lazarus; Colin D Funk; Ying Yu
Journal:  Circ Res       Date:  2013-04-17       Impact factor: 17.367

9.  Rationally evolving MCP-1/CCL2 into a decoy protein with potent anti-inflammatory activity in vivo.

Authors:  Anna Maria Piccinini; Kerstin Knebl; Angelika Rek; Gerhild Wildner; Maria Diedrichs-Möhring; Andreas J Kungl
Journal:  J Biol Chem       Date:  2010-01-22       Impact factor: 5.157

10.  Tissue factor pathway inhibitor gene transfer prevents vascular smooth muscle cell proliferation by interfering with the MCP-3/CCR2 pathway.

Authors:  Yu Fu; Dandan Ma; Yue Liu; Hui Li; Jinyu Chi; Wenxiu Liu; Fang Lin; Jing Hu; Xiaohui Zhang; Minling Zhu; Yong Zhao; Xinhua Yin
Journal:  Lab Invest       Date:  2015-08-24       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.